Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors

NCT00572572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Tumors

Interventions

DRUG: Aprepitant
DRUG: Placebo

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]